Status:
COMPLETED
A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
2-5 years
Phase:
PHASE3
Brief Summary
A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.
Eligibility Criteria
Inclusion
- Male or Female between and including the ages of 2 and 5 years
- Patient was treated with steroids for an asthma episode in the last 3 months
- Patient was admitted to the hospital or emergency room in the last 3 months
- Patient is able to chew a tablet
Exclusion
- Patient has been in a research study in the past 4 weeks
- Patient has visited the emergency room for an asthma episode in the past week
- Patients has a history of stomach, heart, liver, nerve, kidney or blood disease
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2002
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00700661
Start Date
January 1 2001
End Date
December 1 2002
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.